Company / FCF Margin
AIM ImmunoTech Inc. FCF Margin History
FY2016-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-10537.1%
FY2024
5-year range
-11485.1% / -6374.2%
FY2020-FY2024
Trend
+8.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin returned to growth in FY2024 after 2 years of decline, reaching -10537.1%.
Based on SEC 10-K filings.
-10537.1% in FY2024 with a 5-year CAGR of -4012.1%.
Remained stable around -10537.1% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -4162.9pp
- 5-Year Change
- -4012.1pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, fcf margin increased 8.3% year-over-year.
- Peak fcf margin was recorded in FY2018.
- Lowest fcf margin in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | -10537.1% | +8.3% |
| FY2023 | -11485.1% | -10.7% |
| FY2022 | -10374.8% | -62.8% |
| FY2021 | -6374.2% | +0.0% |
| FY2020 | -6374.2% | +2.3% |
| FY2019 | -6525.0% | -124.0% |
| FY2018 | -2913.1% | +76.2% |
| FY2017 | -12250.4% | -49.5% |
| FY2016 | -8195.7% | +33.1% |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026